TIRZEPATIDE
TIRZEPATIDE
2023788-19-2
Dual GIP and GLP-1 receptor agonist peptide for metabolic research.
Accepted: BTC · ETH · USDT
Purity
≥98%
Form
Lyophilized Powder
Storage
-20°C, protect from light, avoid freeze-thaw cycles
Solubility
Reconstitute with bacteriostatic water
Certificate of Analysis available upon request. Contact us to request the COA for this compound.
Research Use Disclaimer
This product is intended solely for in vitro research and development use by trained scientific professionals. It is not intended for human or animal consumption, therapeutic, diagnostic, or clinical use of any kind. The purchaser assumes all responsibility for compliance with applicable laws and regulations governing the acquisition, storage, use, and disposal of research chemicals. SQS makes no representations regarding the safety of this compound for uses other than in vitro laboratory research. Misuse of this product is strictly prohibited.